NFKB1 and ovarian carcinoma: revealed that the activation of the ILK/NF-kB pathway by 12-HETE was found to participate in the inhibition of cell apoptosis, suggesting a crucial potential mechanism that enhances the survival of ovarian cancer cells (44).